Targeting, bio distributive and tumor growth inhibiting characterization of anti-HER2 affibody coupling to liposomal doxorubicin using BALB/c mice bearing TUBO tumors

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.

Demetrios Papahadjopoulos, Theresa M. Allen, Alberto Gabizón et al. · Proceedings of the National Academy of Sciences · 1991 · 1.6K citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.

Rom E. Eliaz, Francis C. Szoka · PubMed · 2001 · 330 citations

Pharmacy, Oncology, Pharmacology +15

Preclinical Efficacy of the Camptothecin-Polymer Conjugate IT-101 in Multiple Cancer Models

Thomas Schluep, Jungyeon Hwang, Jianjun Cheng et al. · Clinical Cancer Research · 2006 · 219 citations · Full text

Pharmacy, Oncology, Pharmacology +15

Trastuzumab-modified nanoparticles: Optimisation of preparation and uptake in cancer cells

I Steinhauser, Birgit Spänkuch, Klaus Strebhardt et al. · Biomaterials · 2006 · 216 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +14

Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin

Leila Arabi, Ali Badiee, Fatemeh Mosaffa et al. · Journal of Controlled Release · 2015 · 183 citations

Pharmacy, Oncology, Pharmacology +17